Citilat en es it fr

Citilat Brand names, Citilat Analogs

Citilat Brand Names Mixture

  • No information avaliable

Citilat Chemical_Formula


Citilat RX_link

Citilat fda sheet

Citilat FDA

Citilat msds (material safety sheet)

Citilat MSDS

Citilat Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Citilat Molecular Weight

346.335 g/mol

Citilat Melting Point

172 - 174 oC

Citilat H2O Solubility


Citilat State


Citilat LogP


Citilat Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Citilat Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Citilat Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Citilat Absorption

Rapidly and fully absorbed following oral administration.

Citilat side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Citilat Patient Information

Citilat Organisms Affected

Humans and other mammals